Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease
CompletedOBSERVATIONAL
Enrollment
233
Participants
Timeline
Start Date
March 15, 2023
Primary Completion Date
April 4, 2025
Study Completion Date
April 4, 2025
Conditions
Chronic or Recovered Hepatitis BChronic or Recovered Hepatitis CChronic or Recovered Hepatitis DNAFLDNASH
Trial Locations (1)
20892
National Institutes of Health Clinical Center, Bethesda
All Listed Sponsors
lead
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
NCT05669677 - Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease | Biotech Hunter | Biotech Hunter